BioSpace News Archive

Pictured: Collage of neuroscience and cancer resea

Deals

Cancer and Neuroscience Led 2023 VC, M&A Investment in Biopharma

The neuroscience space saw a late push in merger and acquisition activity, while oncology start-ups reeled in the most venture capital funds. Industry leaders expect these trends to continue.

February 13, 2024

·

6 min read

·

Heather McKenzie

Pictured: Doctor with tape measure/iStock, Grandbr

Drug Development

BioAge Raises $170M in Series D for Obesity Drug Trial with Lilly’s Zepbound

The startup will use the money to fund a Phase II trial in combination with Eli Lilly’s Zepbound in the hopes of increased weight loss results, while attempting to protect body composition from muscle wasting.

February 13, 2024

·

2 min read

·

Kate Goodwin

Pictured: The inside of a federal courtroom/iStock

Policy

Texas Court Dismisses PhRMA IRA Lawsuit Against Biden Administration

On Monday, the Biden administration got an early victory in pharma’s legal challenge to the Inflation Reduction Act, with a Texas judge dismissing a complaint from the Pharmaceutical Research and Manufacturers of America.

February 13, 2024

·

2 min read

·

Tristan Manalac

Business

Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics

Roche announced that it has entered into an agreement with PathAI, a global leader in artificial intelligence -powered technology for pathology.

February 13, 2024

·

4 min read

Policy

European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted conditional marketing authorization to CASGEVY™, a CRISPR/Cas9 gene-edited therapy.

February 13, 2024

·

8 min read

Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy

Curasight A/S has resolved on a new issue of shares with preferential rights for the Company’s existing shareholders of up to DKK 51.2 million before transaction costs.

February 13, 2024

·

6 min read

Business

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK) today announces a worldwide drug discovery collaboration with Ono Pharmaceutical Co., Ltd. (Ono), to generate novel bifunctional fusion proteins targeting certain pathways in autoimmune and inflammatory diseases.

February 13, 2024

·

5 min read

Business

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Onconetix, Inc. announced the appointment of Ajit Singh, Ph.D. and Thomas Meier, Ph.D. to its Board of Directors.

February 13, 2024

·

5 min read

Business

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

Cingulate Inc. announced that it has appointed three new directors to its board: Jay Roberts, Bryan Lawrence, and Jeff Ervin.

February 13, 2024

·

8 min read

Biotech Beach

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference

Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) today announced that Kimberly Blackwell, M.D., Chief Executive Officer of Zentalis, will participate in a webcast fireside chat at the Oppenheimer Healthcare Life Sciences Conference on Wednesday, February 14, 2024 at 12:40 p.m. ET.

February 13, 2024

·

1 min read